April 11, 2017 / 9:11 AM / 9 months ago

Swiss billionaire Wyss gets nearly 10 percent of Molecular Partners

ZURICH (Reuters) - Swiss billionaire Hansjoerg Wyss has built a nearly 10 percent stake in biotech group Molecular Partners (MOLN.S) after share sales by Johnson & Johnson (JNJ.N) and other investors, the SIX Swiss Exchange said on Tuesday.

Wyss, who made a large share of his fortune by selling med-tech company Synthes Holding AG to J&J in 2012 for nearly $20 billion, now owns 9.85 percent of Molecular Partners, whose products include several prospective cancer and eye disease treatments with partners including Allergan. (AGN.N)

    In addition to J&J, Essex Woodlands Health Ventures and Index Ventures Associates IV Ltd have unloaded stakes this month.

    Beyond ventures in Swiss medical companies, Wyss has given about $225 million to Harvard University and its Wyss Institute for Biologically Inspired Engineering.

    Reporting by John Miller; Editing by Michael Shields

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below